Advances in managing hepatocellular carcinoma.

about

Selective Cytotoxicity of 1,3,4-Thiadiazolium Mesoionic Derivatives on Hepatocarcinoma Cells (HepG2)Clinical observation of liver cancer patients treated with axitinib and cabozantinib after failed sorafenib treatment: a case report and literature review.The lymphatic system and pancreatic cancer.

P2860

Q28548419-EE1AFFDE-40EF-4945-A774-F90AFDD25DE6 Q38350799-A51AAD8F-BB13-439C-A624-F404F7057EE4 Q38689578-202B4B8F-38FA-487C-B730-596C40D097B3

P2860

Advances in managing hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q38210345

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Advances in managing hepatocellular carcinoma.

@en

type

Item

label

Advances in managing hepatocellular carcinoma.

@en

prefLabel

Advances in managing hepatocellular carcinoma.

@en

P1476

Advances in managing hepatocellular carcinoma.

@en

P2093

David K Imagawa

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Invasive growth: a MET-driven genetic programme for cancer and stem cells

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

P2888

s11684-014-0332-4

P304

175-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11684-014-0332-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marielle Reataza

P577

2014-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007276065

http://www.w3.org/2001/XMLSchema#string

P698

24810646

http://www.w3.org/2001/XMLSchema#string

Advances in managing hepatocellular carcinoma.

about

P2860

P2860

Advances in managing hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698